NOVEMBER 2026
The First Opinion Isn't Yours Anymore
The Signal
There is a question health systems have never really had to ask, because the answer was always the same. When a patient first wonders what is wrong with them, where do they go?
For a hundred years, the honest answer was: to us. A doctor, a nurse, a clinic, a call line. The system was the front door to its own care.
That is ending faster than most strategy plans assume. In a forward scenario Advisory Board walked through at SHSMD last month, the first medical opinion a patient seeks is usually an AI chatbot. A meaningful portion of specialty referrals start on a digital platform rather than in a physician's office. You can argue with the exact figures. You cannot argue with the direction. EY’s Global Consumer Health Survey 2026, found that 70% of global consumers have requested or would consider requesting a test, treatment, or prescription based on something they found through a search engine or AI tool.
The patient is now showing up to care having already consulted someone else first. That someone else is not you.
The Shift
From "we are the front door to care" to "we are one stop on a journey that starts, and increasingly gets shaped, somewhere else."
This is bigger than a new technology to evaluate. It is a shift in who holds the first moment of influence, and that moment is worth more than almost any other. Whoever a patient trusts before they reach you is quietly steering what they expect, what they ask for, and sometimes where they go. Advisory Board's framing is apt: patient-facing AI is already shaping expectations for speed and clarity, creating more negotiation in the exam room, and opening decision points between visits that clinicians never see unless they go looking.
Here is the strategic fork, and it is a real one. This can cut two ways, and both are already happening. Done badly, the new journey is more convenient but less coherent: patients over-test on advice from a chatbot, arrive with confident wrong conclusions, fragment their own care across players who don't talk to each other, and manage conditions no one is actually coordinating. Done well, the same tools make care more predictive and more guided: earlier intervention, better navigation to the right setting, episodic visits stitched into something continuous. Advisory Board cited a care-navigation study where guided consumers initiated therapy at several times the rate of those left to find their own way.
The difference between those two futures is not the technology. It is whether the health system decided to shape the journey or just let it happen to them. The front door is being rebuilt whether you participate or not. The only question is whether your fingerprints are on it.
The Move
Stop defending the old front door. Start competing for the new one.
Find out what your patients are actually consulting first, then meet them there. You cannot shape a journey you refuse to look at. If the first opinion is increasingly digital, your presence in that moment, through your own tools, your content, your navigation, is a market-share question, not an IT project.
Make navigation a service you own, not a gap you leave open. If you don't guide patients to the right setting at the right time, a platform with no stake in your network will do it for you, and it will not optimize for you. Guided care is becoming a front-door strategy, not a nicety.
Decide where AI touches the journey on purpose. Map where these tools are already influencing your patients before, during, and between visits. Then choose, deliberately, where you want to lead, where you want to partner, and where you are better off staying out. Drift is the one option that reliably loses.
Compete on coherence, because that is what the new entrants can't easily copy. Fragmentation is the weakness of the unbundled journey. A system that can make care feel connected, that remembers the patient across settings and closes the loop, offers something no standalone app can. That is a durable advantage, if you build for it.
The front door is moving. You can treat that as a threat to survive or a position to win. It will not wait for you to decide.
SPIRTO Insight: Health systems have spent years optimizing the visit. The action has quietly moved to everything that happens before the visit and between visits, and that is precisely the ground most systems have ceded without a fight.
The organizations that matter in five years will be the ones that understood the first moment of trust was up for grabs, and competed for it, while everyone else was still treating the exam room as the beginning of the story.
By the time a patient reaches you, a lot has already been decided. The strategic question is how much of that deciding you want a hand in.
Closing Thought
If the first opinion a patient seeks is no longer yours, then being an excellent destination is no longer enough. You also have to earn your way into the journey that leads there.
So I wouldn't ask, "how do we get more patients through our doors."
I'd ask:
"Before a patient ever reaches us, who are they listening to, and what would it take for that to be us?"
By Paula Serios
Chief Executive Officer, SPIRTO Healthcare Growth Consultancy
If this is something you’re seeing, you’re not alone.
We’ve been helping teams step back and quickly spot where growth and value are out of sync—and what to do about it.
Happy to compare notes in a quick 15-minute SPIRTO Introductory Session.